CDKN2A and glomerulosclerosis: Senolytic approaches, including selective depletion of p16-positive cells using the INK-ATTAC transgenic model and endothelial-specific genetic inactivation of PAI-1, effectively reduced paracrine induction of podocyte apoptosis and ameliorated glomerulosclerosis in aged mice [107].